Edition:
United States

People: Smiths Group PLC (SMIN.L)

SMIN.L on London Stock Exchange

1,582.00GBp
26 May 2017
Change (% chg)

2.00 (+0.13%)
Prev Close
1,580.00
Open
1,582.00
Day's High
1,584.00
Day's Low
1,570.00
Volume
1,044,112
Avg. Vol
1,436,627
52-wk High
1,685.00
52-wk Low
1,028.00

Angelici, Bruno 

Mr. Bruno F. J. Angelici is Non-Executive Independent Director of Smiths Group Plc. Mr. Bruno has Business and Law degrees from Reims and an MBA from Kellogg School of Management. His career includes senior management roles in pharmaceutical and medical device companies. Bruno retired from AstraZeneca in 2010 as Executive Vice President, International after a 20-year career. He was responsible for Europe, Japan, Asia Pacific, Latin America, Middle East and Africa and originally joined as President of ICI Pharma France. Prior to this, he was at Baxter, a US-based global supplier of medical devices. He has extensive international experience, including in the US, and brings a deep understanding to the Group of the medical device and pharmaceutical industries.

Basic Compensation

Total Annual Compensation, GBP 75,000
Restricted Stock Awards, GBP --
Long-Term Incentive Plans, GBP --
All Other, GBP --
Fiscal Year Total, GBP 75,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

George Buckley

518,000

Andrew Smith

2,964,000

Chris O'Shea

1,862,000

Melanie Rowlands

--

Bruno Angelici

75,000

Tanya Fratto

120,000
As Of  30 Jul 2016